Literature DB >> 32291811

Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.

Syed Mahamad1, Elle Wadsworth1, Vicki Rynard1, Samantha Goodman1, David Hammond1.   

Abstract

INTRODUCTION AND AIMS: There is little objective market data on the price or potency of legal and illegal cannabis products following recreational cannabis legalisation. DESIGN AND METHODS: In the 2 months post-legalisation in Canada (November-December 2018), legal and illegal cannabis retailers were identified from government lists and online directories. The store location, price and Δ9-tetrahydrocannabinol (THC) and cannabidiol levels of dried herb and cannabis cookies were collected from retailer websites or Weedmaps.
RESULTS: We identified 185 legal retailers (22 online stores, 163 storefronts; 65 government-run stores, 120 private stores) and 944 illegal retailers (791 delivery-only services, 157 storefronts). Relative to legal dried herb, illegal dried herb was lower in price (1 g: $10.23 vs. $11.08, ⅛ oz: $9.37/g vs. $10.88/g, ½ oz: $8.18/g vs. $8.85/g; P < 0.05 for all) and higher in potency (THC: 20.5% vs. 16.1%, cannabidiol: 2.4% vs. 1.7%; P < 0.05 for both). Legal private stores had higher prices for dried herb than government-run stores (1 g: $13.08 vs. $10.89, ⅛ oz: $12.75/g vs. $10.45/g, ½ oz: $10.85/g vs. $8.71/g, 1 oz: $8.54/g vs. $7.22/g; P < 0.05 for all). On average, one cannabis cookie in the illegal market contained 96 mg of THC and cost $1.57 per 10 mg of THC. DISCUSSION AND
CONCLUSIONS: In the 2 months post-legalisation, illegal cannabis was less expensive, with higher labelled THC content than legal cannabis, although the scope of these differences was more modest than estimates from other crowdsourced and self-reported data. Direct monitoring of cannabis price and potency from legal and illegal retailers is needed to examine the impact of legalisation over time.
© 2020 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  cannabis; drug; health policy; legalisation

Mesh:

Substances:

Year:  2020        PMID: 32291811     DOI: 10.1111/dar.13069

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  12 in total

1.  A social media intervention for cannabis use among emerging adults: Randomized controlled trial.

Authors:  Erin E Bonar; Jason E Goldstick; Lyndsay Chapman; José A Bauermeister; Sean D Young; Jenna McAfee; Maureen A Walton
Journal:  Drug Alcohol Depend       Date:  2022-02-03       Impact factor: 4.852

2.  Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.

Authors:  David Hammond; Samantha Goodman
Journal:  Cannabis Cannabinoid Res       Date:  2020-10-29

3.  Use and Perceptions of Cannabidiol Products in Canada and in the United States.

Authors:  Samantha Goodman; Elle Wadsworth; Gillian Schauer; David Hammond
Journal:  Cannabis Cannabinoid Res       Date:  2020-11-20

4.  THC labeling on cannabis products: an experimental study of approaches for labeling THC servings on cannabis edibles.

Authors:  Samantha Goodman; David Hammond
Journal:  J Cannabis Res       Date:  2022-04-07

5.  Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.

Authors:  Howard Padwa; David Huang; Larissa Mooney; Christine E Grella; Darren Urada; Douglas S Bell; Brittany Bass; Anne E Boustead
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-05-08

6.  Home cultivation across Canadian provinces after cannabis legalization.

Authors:  Elle Wadsworth; Nick Cristiano; Karen Pacheco; Rebecca Jesseman; David Hammond
Journal:  Addict Behav Rep       Date:  2022-03-25

Review 7.  Violence and Cannabis Use: A Focused Review of a Forgotten Aspect in the Era of Liberalizing Cannabis.

Authors:  Laura Dellazizzo; Stéphane Potvin; Maria Athanassiou; Alexandre Dumais
Journal:  Front Psychiatry       Date:  2020-09-16       Impact factor: 4.157

Review 8.  Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health.

Authors:  Justin Matheson; Bernard Le Foll
Journal:  Front Psychiatry       Date:  2020-09-23       Impact factor: 4.157

9.  Cannabis use prior to legalisation among alcohol consumers in the Canadian Yukon and Northwest territories.

Authors:  David Hammond; Samantha Goodman; Erin Hobin
Journal:  Int J Circumpolar Health       Date:  2021-12       Impact factor: 1.228

Review 10.  Characteristics that influence purchase choice for cannabis products: a systematic review.

Authors:  Jennifer Donnan; Omar Shogan; Lisa Bishop; Michelle Swab; Maisam Najafizada
Journal:  J Cannabis Res       Date:  2022-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.